BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24251827)

  • 1. Cell membranes open "doors" for cationic nanoparticles/biomolecules: insights into uptake kinetics.
    Lin J; Alexander-Katz A
    ACS Nano; 2013 Dec; 7(12):10799-808. PubMed ID: 24251827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
    Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
    Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics of cell-penetrating HIV1 TAT peptide insertion into PC/PS/CHOL model bilayers through transmembrane pores: the roles of cholesterol and anionic lipids.
    Hu Y; Patel S
    Soft Matter; 2016 Aug; 12(32):6716-27. PubMed ID: 27435187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of HIV-1 TAT peptide and its conjugated gold nanoparticles translocating across lipid membranes.
    Quan X; Sun D; Zhou J
    Phys Chem Chem Phys; 2019 May; 21(20):10300-10310. PubMed ID: 31070638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Delivery of Nanoparticles with Cell Penetrating Peptides.
    Salzano G; Torchilin VP
    Methods Mol Biol; 2015; 1324():357-68. PubMed ID: 26202282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells.
    Peng LH; Niu J; Zhang CZ; Yu W; Wu JH; Shan YH; Wang XR; Shen YQ; Mao ZW; Liang WQ; Gao JQ
    Biomaterials; 2014 Jul; 35(21):5605-18. PubMed ID: 24736021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Intracellular Delivery of Polyarginine Peptides with Cargoes.
    Hu J; Lou Y; Wu F
    J Phys Chem B; 2019 Mar; 123(12):2636-2644. PubMed ID: 30830784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into cell-entry mechanisms of CPPs by electron microscopy.
    Padari K; Lorents A; Jokitalo E; Pooga M
    Methods Mol Biol; 2011; 683():181-93. PubMed ID: 21053130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship.
    Lin J; Zhang H; Chen Z; Zheng Y
    ACS Nano; 2010 Sep; 4(9):5421-9. PubMed ID: 20799717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
    Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
    J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane potential drives direct translocation of cell-penetrating peptides.
    Gao X; Hong S; Liu Z; Yue T; Dobnikar J; Zhang X
    Nanoscale; 2019 Jan; 11(4):1949-1958. PubMed ID: 30644958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution NMR studies of cell-penetrating peptides in model membrane systems.
    Mäler L
    Adv Drug Deliv Rev; 2013 Jul; 65(8):1002-11. PubMed ID: 23137785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
    Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverted micelle formation of cell-penetrating peptide studied by coarse-grained simulation: importance of attractive force between cell-penetrating peptides and lipid head group.
    Kawamoto S; Takasu M; Miyakawa T; Morikawa R; Oda T; Futaki S; Nagao H
    J Chem Phys; 2011 Mar; 134(9):095103. PubMed ID: 21385001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.